Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
08/2003
08/14/2003US20030153506 Anticoagulant therapy; multicompartment kits, synergistic effect using the mixtures
08/14/2003US20030153504 Antiinflammatory agents selects from a group of tetrapeptides, hexapeptides, octapeptides, oligopeptides, polypeptides
08/14/2003US20030153487 Use of npy y1 receptor antagonists in the treatment of inflammatory conditions
08/14/2003US20030153082 An isolated population of human hematopoietic cells that proliferates in culture, obtained by differentiating primate pluripotent stem (pPS) cells, and atleast 1% cells are CD45 + and population forms colonies
08/14/2003US20030153073 Expansion of T cells in vitro and expanded T cell populations
08/14/2003US20030153046 Interferon gamma conjugates
08/14/2003US20030152973 G-protein coupled receptor org3
08/14/2003US20030152970 Methods and compositions to treat pain and painful disorders using 577, 20739 or 57145
08/14/2003US20030152947 Methods for detecting and treating the early onset of aging-related conditions
08/14/2003US20030152637 Administering by injection; glycolic acid-lactic acid copolymer; sustained release particles
08/14/2003US20030152617 Capsule, tablet with enteric, protective coatings; bioavailability
08/14/2003US20030152611 Pharmaceutical compositions for transdermal administration of anti-inflammatory agents
08/14/2003US20030152600 Novel compounds of the n-acylamino-amide-family, cpmpositions comprising same, and uses
08/14/2003US20030152594 Immunology response intensifiers; administering a bacterial lysate
08/14/2003US20030152585 Herbal formulation
08/14/2003US20030152572 Blocking production of synoviocytes; antiinflammatory agents; prevent signal transduction
08/14/2003US20030152571 Anti-alphabeta3 humanized monoclonal antibodies
08/14/2003US20030152552 Synergistic mixture; viricides, antiproliferative agents, antiinflammatory agents; side effect reduction
08/14/2003DE3546944C2 Synergistic analgesic and antiinflammatory compsn.
08/14/2003DE10201747C1 Glas-Keramik-Komposit, Verfahren zu seiner Herstellung und Verwendungen Glass-ceramic composite, method for its preparation and uses
08/14/2003CA2485064A1 Albumin-fused kunitz domain peptides
08/14/2003CA2483630A1 Compositions and methods for modulation of effects on phagocyte and lymphoid cell populations
08/14/2003CA2476281A1 Pyrimidine compounds
08/14/2003CA2476214A1 Proliferated cell lines and uses thereof
08/14/2003CA2475767A1 Opioid receptor active 4-(3-hydroxyphenyl) or 4-(3-alkoxyphenyl)-1,2,4-triazole compounds
08/14/2003CA2475637A1 Quinolinone derivatives for treating cell proliferation related disorders
08/14/2003CA2475539A1 Hiv inhibiting proteins
08/14/2003CA2475382A1 Albumin-fused anti-angiogenesis peptides
08/14/2003CA2475349A1 Polyamine compounds and compositions for use in conjunction with cancer therapy
08/14/2003CA2475329A1 Truncated aggrecanase molecules
08/14/2003CA2475247A1 Anti-pathogen treatments
08/14/2003CA2475209A1 Use of co-releasing compounds for the manufacture of a medicament for the treatment of inflammatory diseases
08/14/2003CA2474974A1 Cytoprotective benzofuran derivatives
08/14/2003CA2474921A1 Pharmaceutical tablet
08/14/2003CA2474917A1 Granzyme b inhibitors
08/14/2003CA2474748A1 Inhibitors of alpha l beta 2 integrin mediated cell adhesion
08/14/2003CA2474508A1 Ansamycins having improved pharmacological and biological properties
08/14/2003CA2474186A1 Compositions and methods for restoring immune responsiveness in patients with immunological defects
08/14/2003CA2474027A1 Water soluble phenylglycine derivatives
08/14/2003CA2474016A1 A combination for treating cold and cough
08/14/2003CA2474011A1 Use of the mammalian cytokine, tslp/il-50, for modulating dendritic cell activity and treatment of immune disorders
08/14/2003CA2473778A1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives
08/14/2003CA2473143A1 Compositions containing oat straw and willowherb extract
08/14/2003CA2467555A1 Preparation of pharmaceutical salts of 4 ( (z) - (4-bromophenyl) (ethoxyimino) methyl)-1'-( (2,4-dimethyl-1-oxido-3-pyridinyl) carbonyl) -4'-me thyl-1,4' bipiperidine as ccr5-antagonists for the treatment of aids and related hiv infections
08/14/2003CA2466251A1 Therapeutic use of aziridino compounds
08/14/2003CA2450807A1 Non-myeloablative tolerogenic treatment with tyrphostins
08/13/2003EP1334717A2 Pharmaceutical Compositions For Oral And Topical Administration
08/13/2003EP1334207A2 Methods and compositions for the treatment of inflammatory diseases
08/13/2003EP1334186A2 Nucleic acid generating the abca7 gene, molecules modulating its activity and therapeutic applications
08/13/2003EP1334179A2 A human serpin secreted from lymphoid cells lsi-01
08/13/2003EP1334174A2 Paramyxovirus vector for gene transfer to the cardiovascular system
08/13/2003EP1334102A1 Bombesin receptor antagonists
08/13/2003EP1334100A1 Bombesin receptor antagonists
08/13/2003EP1334098A2 Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for treating of nervous systems disorders
08/13/2003EP1334089A1 Quinoline derivatives as nk-3 and nk-2 antagonists
08/13/2003EP1334088A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
08/13/2003EP1334086A1 Phenoxyphenyl alkane sulfonates
08/13/2003EP1333859A2 Anti-adhesion molecule antibody to treat inflammation and cancer by inducing the idiotypic network
08/13/2003EP1333841A2 M. tuberculosis chaperonin 10 and uses thereof
08/13/2003EP1333840A2 M. tuberculosis chaperonin 60.1 and uses thereof
08/13/2003EP1333839A1 Method for the treatment of inflammation
08/13/2003EP1333834A2 Antiinflammation agents
08/13/2003EP1333833A2 Novel compounds
08/13/2003EP1333830A2 Novel medicament compositions based on anticholinergics and corticosteroids
08/13/2003EP1333821A2 Novel uses of combined selective dopamine d2 receptor antagonists and 5-ht1a receptor agonists
08/13/2003EP1333809A2 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress
08/13/2003EP1333805A2 Cosmetic method of treating skin
08/13/2003EP1242427B1 Novel piperidine and piperazine derivatives as p2x7 receptor antagonists
08/13/2003EP1222193B1 Imidazole derivatives as phosphodiesterase vii inhibitors
08/13/2003EP1220845B1 Aryl-sulfonamide substituted benzimidazol derivatives and use of said as tryptase inhibitors
08/13/2003EP1165540B1 Tetrahydropyran derivatives and their use as therapeutic agents
08/13/2003EP1143942B1 Use of gaba-b receptor ligands for the manufacture of medicaments for the treatment of neurodegenerative diseases
08/13/2003EP1140943B1 Substituted pyrroloindoles
08/13/2003EP1034174B1 Azaring-ether derivatives and their use as nicotinic ach receptor modulators
08/13/2003EP0971948B1 Inhibitors for urokinase receptor
08/13/2003EP0923568B9 Novel benzofuran-4-carboxamides
08/13/2003EP0904092B1 Purified extract of harpagophytum procumbens and/or harpagophytum zeyheri dence, process for its production and its use
08/13/2003EP0891328B1 Peptidyl compounds having mmp and tnf inhibitory activity
08/13/2003EP0814809B1 Aryl thioxanthines
08/13/2003EP0665843B1 Substituted quinuclidines as substance p antagonists
08/13/2003EP0614374B1 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES
08/13/2003CN1436197A Novel compounds of N-acylamino-amide family, compositions comprising same and uses
08/13/2003CN1436196A Pyridine-2-yl-aminoalkyl carbonyl glycyl-beta-alanine and derivs. thereof
08/13/2003CN1436195A Integrin binding peptide derivatives
08/13/2003CN1436188A 1,3,8-triaza-spiroÒÇö4,5ÒÇòdecan-4-one derivs. as neurokinin receptor antagonists
08/13/2003CN1436186A Process for preparation of sulfonamide derivs. and crystals thereof
08/13/2003CN1436185A Thrombin receptor antagonists
08/13/2003CN1436180A Diamino phenothiazine derivs. and composition comprising same
08/13/2003CN1436174A HMG-CoA reductase inhibitors and their use as medicaments for treatment of cholesterol related diseases
08/13/2003CN1436086A Interferon for treatment of multiple sclerosis
08/13/2003CN1436085A Method for treating pain by peripheral administration of neurotoxin
08/13/2003CN1436072A Composition, kits, and methods for promoting defined health benefits
08/13/2003CN1435433A Long-acting broad-spectrum chemotactic factor receptor inhibiting matter
08/13/2003CN1435256A Oral collagen Ôàí film preparation
08/13/2003CN1435251A ÔÇ£SanhuangÔÇØ drip pill and preparing method thereof
08/13/2003CN1435245A Capsule for alleviating pains of neck, shoulder waist and leg
08/13/2003CN1435240A Medicine for treating rheumatism
08/13/2003CN1435239A Method for preparing tablet for activating blood circulation and alleviating pain
08/13/2003CN1435235A Medicinal liquid for activating meridians
08/13/2003CN1435223A Externally applied medicinal stasis-and swelling-eliminating powder for treating chronic pelvic inflammation
1 ... 820 821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 838 839 840 ... 1272